Počet záznamov: 1
XII. Výročný medzinárodný kongres Medzinárodnej spoločnosti pre farmakoekonomiku a výskum výsledkov, Washington, 19.-23. V. 2007
Názov XII. Výročný medzinárodný kongres Medzinárodnej spoločnosti pre farmakoekonomiku a výskum výsledkov, Washington, 19.-23. V. 2007 Aut. údaje Ján Bielik Autor Bielik Ján
Korporácia Medzinárodná spoločnosť pre farmakoekonomiku a výskum výsledkov. Medzinárodný kongres 12., 2007, Washington, USA
Poznámky Voľný preklad z kongresových materiálov Sign. C 3079 Zdroj. dok. Farmakoekonomika a lieková politika : oficiálny časopis Slovenskej spoločnosti pre farmakoekonomiku. - ISSN 1336-7021. - Nové Mesto nad Váhom : TISING , 2007 . - Roč. 3, č. 3 (2007), s. 41-46 a 48-56 Obsahuje tiež Non-persistent use of antihypertensive drugs leads to increased risk of hospitalizations for stroke / Breekveldt-Postma, N. S. a kol. -- Non-persistent use of antihypertensive drugs increases risk of acute myocardial infarction by 10% in low/intermediate cardiovascular risk patients / Breekveldt-Postma N. S. a kol. -- Hypertension may not influence cardiovascular benefits of statin therapy: results from a meta-regression analysis of 69984 patients / Franz H. Messerli a kol. -- Analysis of clopidogrel use in outpatient settings / Jay P. Bae a kol. -- Cost-effectiveness among brand and generic statins based on real-world effectiveness: implications for statin formulary design / Robert L. Ohsfeldt a kol. -- A cost-effectiveness analysis for prophylactic therapies against air traveler thrombosis / Joshua J. Spooner a kol. -- Clinical and economic burden of Nonadherence to lipid-lowering and antihypertensive therapy in a hypertensive population / Joshua S. Benner a kol. -- Burden of illness among patients at high risk for major cardiovascular events / Harley C. a kol. -- Cost-effectiveness landscape of genetic testing with warfarin therapy / Lisa M. Meckley a kol. -- Is meta-analysis always a good idea? / James G. Xenakis a kol. -- Characterization of hypertensive patients who might benefit from a combination of drugs in 1 pill for reduction of cardiovascular risk / Miriam C. J. M. Sturkenboom a kol. -- Trend analyses in obesity and the related comorbidities and medical costs in the US / Gordon G. Liu a kol. -- Cost-effectiveness of rosuvastatin compared with other statins from a managed care perspective / Joshua S. Bener a kol. -- Cumulative persistence of antihypertensive medication as a newly prescribed drug in a medicaid population / Anna Gu a kol. -- Influence of hemoglobin A1c test results on decision to initiate insulin supplementation in type 2 diabetes / Emily Durden a kol. -- Treatment costs attributable to overweight and obesity in patients with diabetes mellitus in the US adult population / Chulmin Kim a kol. -- Price and utilization of oral anti-diabetic medications from 1991 to 2005 in US medicaid programs / Xing Li a kol. -- Body weight gain experienced by diabetic patients due to thiazolidinediones (TZD): Meta-analysis of published randomized short-term clinical trials / Phatak H. M. a kol. -- Impact of initiating or converting to treatment with an insulin aspart analog pen on medication adherence in type 2 diabetes patients on vial/syringe insulin / Sanjeev Balu a kol. -- Economic outcomes associated with switching to insulin pen therapy in medicaid type 2 diabetes patients: a retrospective database analysis / Manjiri D. Pawaskar a kol. -- Comparisons of rosiglitazone versus pioglitazone monotherapy introduction and associated healtcare utilization in type 2 diabetes medicaid enrollees / Rajesh Balkrishnan a kol. -- Budget impact analysis of pioglitazone for diabetes in taiwan: a retrospective database analysis / Sung-Ling Tang a kol. -- Direct and indirect costs associated with photocoagulation and vitrectomy among employees with diabetic retinopathy / Andrew P. Yu a kol. -- Medication adherence in patients with diabetes / Karim Prasla a kol. -- Determination of health care costs imcurred by Swedish patients with type 2 diabetes / Ringborg A. a kol. -- Copayment level and medication adherence in type 2 diabetes patients managed with insulin aspart pen therapy / Won Chan Lee a kol. -- Emergency room care for diabetes mellitus in the United states: how much does its cost? / Joyce Addo-Atuah a kol. -- The impact of consumer driven health plans (CDHP) on utilization, adherence and expenditures / Nair K. V. a kol. -- More policy initiatives in the Australian national reimbursement system that reduce costs dramatically / Davey P. J. a kol. -- Did FDAMA section 114 lead to a decline of economic-content drug advertising in medical journals? / Jennifer A. Palmer a kol. -- Analysis of cummunity pharmacists interventions on electronic prescription errors / Terri Warholak Jackson a kol. -- Comparing generic dispensing rates in three retail channels / Nikhil G. Khandelwal a kol. -- Dispensing errors in community pharmacy: impact of sociotechnical factors / Ashish A. Parekh a kol. -- Quality assessment of pharmacoeconomic evaluations submitted for reimbursement in Korea / Sang Hee Lim a kol. -- The pediatric exclusivity incentive and its impacts on pharmaceutical industry behavior and generic drug entries / Jinnie Rhee a kol. Rozšírený názov Dvanásty Výročný medzinárodný kongres Medzinárodnej spoločnosti pre farmakoekonomiku a výskum výsledkov, Washington, 19.-23. V. 2007 Jazyk dok. slovenčina Krajina Slovenská republika Druh dok. Rozpis článkov z periodík Báza dát ČLÁNKY 
článok
Počet záznamov: 1